Gene · 7827
Papers2,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,376
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Content Screening of Wind-Dampness Dispelling Traditional Chinese Medicines against Podocyte EMT Induced by IgA1. | Comb Chem High Throughput Screen | 2026 | 40304343 | PubTator, text mining | PubMed |
| Spatially segregated multiomics decodes metformin-mediated function-specific metabolic characteristics in diabetic kidney disease. | Life Metab | 2025 | 42058134 | PubTator, text mining | PubMed |
| Reflective versus predictive value of urinary podocin, nephrin, and their ratio in diabetic kidney disease: a 12-month retrospective cohort study. | Front Nephrol | 2025 | 41647321 | PubTator, text mining | PubMed |
| [Treatment and Prospects of Focal Segmental Glomerulosclerosis]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536662 | PubTator, text mining | PubMed |
| Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca. | Med Pharm Rep | 2025 | 41496885 | PubTator, text mining | PubMed |
| Mass Spectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis. | Kidney Int Rep | 2025 | 41426026 | PubTator, text mining | PubMed |
| Genetic and environmental factors associated with alteration of filtration slit proteins and their functions: a scoping review. | Front Nephrol | 2025 | 41368354 | PubTator, text mining | PubMed |
| The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes. | BMC Nephrol | 2025 | 41353143 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing for Molecular Diagnosis of Paediatric Nephrotic Syndrome in Africa: A Call for Implementation. | Genes (Basel) | 2025 | 41300747 | PubTator, text mining | PubMed |
| Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line. | Stem Cell Res Ther | 2025 | 41225540 | PubTator, text mining | PubMed |
| Multiscale Construction, Evaluation, and Application of Organoids. | Adv Sci (Weinh) | 2025 | 41214890 | PubTator, text mining | PubMed |
| TRPC6 effects on albumin permeation, nephrin shedding, and apoptosis in podocytes: Role of calcineurin and metalloproteases. | Physiol Rep | 2025 | 41165237 | PubTator, text mining | PubMed |
| Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial. | Ann Med | 2025 | 41145267 | PubTator, text mining | PubMed |
| Anti-podocin Enzyme-Linked Immunosorbent Assay Guides Immunotherapy in Steroid-Resistant Nephrotic Syndrome. | Kidney Int Rep | 2025 | 41141520 | PubTator, text mining | PubMed |
| Serum Factors in Primary Podocytopathies. | Antibodies (Basel) | 2025 | 41133676 | PubTator, text mining | PubMed |
| Editorial: Exploring the impact of biologics in nephrology: clinical advances and future perspectives. | Front Med (Lausanne) | 2025 | 41090125 | PubTator, text mining | PubMed |
| Podocytes in health and disease: from development to regeneration. | Hum Cell | 2025 | 41037130 | PubTator, text mining | PubMed |
| Beyond Antibodies in Post-Transplant FSGS: New Answers or Recurrent Questions? | Transpl Int | 2025 | 41000179 | PubTator, text mining | PubMed |
| A case of post-transplant recurrent focal segmental glomerulosclerosis: graft biopsy showing IgG colocalization with Nephrin, Podocin, and Kirrel1. | Kidney Int | 2025 | 40975534 | PubTator, text mining | PubMed |
| iPSC line DHMCi010-A is derived from a hereditary nephrotic syndrome patient with an autosomal recessive NPHS2 mutation. | Stem Cell Res | 2025 | 40974781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7827/papers?page=4